Janus Henderson Group PLC trimmed its holdings in shares of Healthequity Inc (NASDAQ:HQY) by 4.4% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,020,291 shares of the company’s stock after selling 92,739 shares during the period. Janus Henderson Group PLC owned about 3.34% of Healthequity worth $102,186,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also modified their holdings of the company. Grandeur Peak Global Advisors LLC bought a new stake in shares of Healthequity in the 3rd quarter valued at about $510,000. Engineers Gate Manager LP bought a new stake in shares of Healthequity in the 3rd quarter valued at about $678,000. Aureus Asset Management LLC boosted its holdings in shares of Healthequity by 0.9% in the 3rd quarter. Aureus Asset Management LLC now owns 178,642 shares of the company’s stock valued at $9,036,000 after buying an additional 1,680 shares in the last quarter. Envestnet Asset Management Inc. bought a new stake in shares of Healthequity in the 3rd quarter valued at about $273,000. Finally, Private Advisor Group LLC bought a new stake in shares of Healthequity in the 3rd quarter valued at about $241,000. Institutional investors own 98.60% of the company’s stock.

Healthequity Inc (NASDAQ:HQY) opened at $44.80 on Friday. Healthequity Inc has a 1 year low of $37.62 and a 1 year high of $55.31. The stock has a market cap of $2,690.00, a P/E ratio of 62.51, a price-to-earnings-growth ratio of 1.81 and a beta of 1.74.

Healthequity (NASDAQ:HQY) last posted its quarterly earnings results on Tuesday, December 5th. The company reported $0.17 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.13 by $0.04. Healthequity had a net margin of 21.08% and a return on equity of 14.47%. The company had revenue of $56.80 million during the quarter, compared to analyst estimates of $55.27 million. During the same period last year, the firm posted $0.10 EPS. Healthequity’s revenue for the quarter was up 31.0% compared to the same quarter last year. analysts anticipate that Healthequity Inc will post 0.71 EPS for the current year.

HQY has been the subject of a number of recent analyst reports. BidaskClub upgraded shares of Healthequity from a “sell” rating to a “hold” rating in a research note on Thursday, September 28th. Cantor Fitzgerald reiterated a “buy” rating and issued a $56.00 target price on shares of Healthequity in a research note on Tuesday, December 5th. Chardan Capital lifted their target price on shares of Healthequity from $58.00 to $62.00 and gave the stock a “buy” rating in a research note on Wednesday, December 6th. Robert W. Baird reiterated a “hold” rating on shares of Healthequity in a research note on Thursday, September 21st. Finally, Oppenheimer reiterated a “buy” rating and issued a $61.00 target price on shares of Healthequity in a research note on Wednesday, September 6th. One research analyst has rated the stock with a sell rating, two have given a hold rating and eight have issued a buy rating to the company. Healthequity currently has a consensus rating of “Buy” and a consensus price target of $58.33.

In other news, EVP Delano Ladd sold 26,405 shares of Healthequity stock in a transaction that occurred on Tuesday, December 12th. The shares were sold at an average price of $43.32, for a total transaction of $1,143,864.60. Following the completion of the transaction, the executive vice president now directly owns 16,692 shares of the company’s stock, valued at approximately $723,097.44. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, VP Ashley Dreier sold 10,000 shares of Healthequity stock in a transaction that occurred on Monday, December 4th. The shares were sold at an average price of $50.97, for a total transaction of $509,700.00. Following the transaction, the vice president now directly owns 15,652 shares of the company’s stock, valued at $797,782.44. The disclosure for this sale can be found here. Insiders have sold a total of 1,761,117 shares of company stock valued at $91,904,676 over the last three months. 29.00% of the stock is currently owned by insiders.

TRADEMARK VIOLATION WARNING: “Janus Henderson Group PLC Sells 92,739 Shares of Healthequity Inc (HQY)” was originally posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this article on another site, it was copied illegally and republished in violation of U.S. & international copyright legislation. The original version of this article can be viewed at https://www.thecerbatgem.com/2017/12/15/janus-henderson-group-plc-sells-92739-shares-of-healthequity-inc-hqy.html.

Healthequity Company Profile

HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.

Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Healthequity Inc (NASDAQ:HQY).

Institutional Ownership by Quarter for Healthequity (NASDAQ:HQY)

Receive News & Stock Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related stocks with our FREE daily email newsletter.